Clinical Trial

Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application

Study acronym: SYN 20-01
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2021-10-22; most recent amendment 2026-01-16.
Status change: Recruiting → Active, Not Recruiting 2026-01-16
Status change: Not Yet Recruiting → Recruiting 2022-12-20
Trial Details
NCT Number NCT05094089
Lead Sponsor W.L.Gore & Associates
Conditions Hernia, Ventral, Hernia Incisional, Hernia Incisional Ventral
Enrollment 320 participants
Start Date 2023-02-24
Primary Completion 2030-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-21